Display Settings:

Format

Send to:

Choose Destination
    J Clin Oncol. 2008 Feb 10;26(5):729-35.

    Clinical application of the 70-gene profile: the MINDACT trial.

    Source

    Jules Bordet Institute, Blvd de Waterloo, 125, 1000 Brussels, Belgium.

    Abstract

    The 70-gene profile is a new prognostic tool that has the potential to greatly improve risk assessment and treatment decision making for early breast cancer. Its prospective validation is currently ongoing through the MINDACT (Microarray in Node-Negative Disease May Avoid Chemotherapy) trial, a 6,000-patient randomized, multicentric trial. This article reviews the several steps in the development of the profile from its discovery to its clinical validation.

    PMID:
    18258980
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk